Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats

---

Akaslan S. B., Degertekin C. K., Yilmaz G., Cakir N., Arslan M., TÖRÜNER F. S.

METABOLIC SYNDROME AND RELATED DISORDERS, vol.11, no.4, pp.243-250, 2013 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 11 Issue: 4
• Publication Date: 2013
• Doi Number: 10.1089/met.2012.0128
• Journal Name: METABOLIC SYNDROME AND RELATED DISORDERS
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.243-250
• Gazi University Affiliated: Yes

Abstract

Background: Studies investigating the effects of dipeptidyl peptidase-4 inhibitors on hepatic steatosis are lacking. We aimed to determine the effects of sitagliptin on nonalcoholic fatty liver disease (NAFLD) in rats with diet-induced obesity.